DOTOMO
ActiveSummary
DOTOMO has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €179,102 and a net result of €94,269. Equity is growing by about 91% per year across the filed financial years. Its solvency ranks better than 70% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
- Equity
- €179,102
- Profit
- €94,269
Why 98raises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.65, cash €136,701Equity €179,102 (80.0% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 87% on liquidity, 80% on profitability and 91% on growth.
The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 3 accounts on average 55 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Highest result from 2023 to 2025net €94,269 ▲58.7%
- Liquidity more than doubledcurrent ratio 6.65
Financials · financial year 2025, micro format
2023 to 2025, 3 financial years
The operating result has risen two years in a row; 2025 is 61% above 2024 and is the highest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Peer companies
Historical observationOf the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.9% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €203 | €16,167 | €16,367 | ▲ 1.2% |
| Other operating charges640/8 | €404 | €2,458 | €239 | ▼ 90.3% |
| Non-recurring operating charges66A | - | €120 | €0 | ▼ 100% |
| Gross operating margin9900 | €28,992 | €96,830 | €142,041 | ▲ 46.7% |
| Operating profit (loss)9901 | €28,385 | €78,085 | €125,436 | ▲ 60.6% |
| Financial income75/76B | - | - | €1 | - |
| Recurring financial income75 | - | - | €1 | - |
| Financial charges65/66B | €20 | €2,116 | €1,671 | ▼ 21.0% |
| Recurring financial charges65 | €20 | €2,116 | €1,671 | ▼ 21.0% |
| Profit (loss) for the period before taxes9903 | €28,365 | €75,970 | €123,766 | ▲ 62.9% |
| Income taxes67/77 | €5,922 | €16,580 | €29,497 | ▲ 77.9% |
| Profit (loss) for the period9904 | €22,443 | €59,390 | €94,269 | ▲ 58.7% |
| Profit (loss) for the period to be appropriated9905 | €22,443 | €59,390 | €94,269 | ▲ 58.7% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €90,500 | €150,711 | €223,802 | ▲ 48.5% |
| Fixed assets21/28 | €59,374 | €48,337 | €31,970 | ▼ 33.9% |
| Tangible fixed assets22/27 | €59,374 | €48,337 | €31,970 | ▼ 33.9% |
| Plant, machinery and equipment23 | - | €1,568 | €808 | ▼ 48.5% |
| Furniture and vehicles24 | €59,374 | €46,769 | €31,162 | ▼ 33.4% |
| Current assets29/58 | €31,126 | €102,375 | €191,832 | ▲ 87.4% |
| Amounts receivable within one year40/41 | €23,228 | €0 | €26,916 | - |
| Trade receivables40 | €23,228 | €0 | €26,766 | - |
| Other amounts receivable41 | - | - | €150 | - |
| Current investments50/53 | - | €2,000 | €26,000 | ▲ 13× |
| Cash at bank and in hand54/58 | €7,537 | €99,901 | €136,701 | ▲ 36.8% |
| Deferred charges and accrued income490/1 | €361 | €473 | €2,215 | ▲ 368% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €90,500 | €150,711 | €223,802 | ▲ 48.5% |
| Equity10/15 | €25,443 | €84,833 | €179,102 | ▲ 111% |
| Contributions10/11 | €3,000 | €3,000 | €3,000 | = |
| Profit (loss) carried forward14 | €22,443 | €81,833 | €176,102 | ▲ 115% |
| Amounts payable17/49 | €65,057 | €65,878 | €44,700 | ▼ 32.1% |
| Amounts payable after more than one year17 | €45,004 | €30,583 | €15,589 | ▼ 49.0% |
| Financial debts170/4 | €45,004 | €30,583 | €15,589 | ▼ 49.0% |
| Amounts payable within one year42/48 | €19,791 | €35,033 | €28,840 | ▼ 17.7% |
| Current portion of amounts payable after more than one year42 | €13,869 | €14,421 | €14,994 | ▲ 4.0% |
| Trade debts44 | - | €4,032 | €350 | ▼ 91.3% |
| Suppliers440/4 | - | €4,032 | €350 | ▼ 91.3% |
| Taxes, remuneration and social security45 | €5,922 | €16,580 | €13,497 | ▼ 18.6% |
| Taxes450/3 | €5,922 | €16,580 | €13,497 | ▼ 18.6% |
| Accrued charges and deferred income492/3 | €262 | €262 | €271 | ▲ 3.1% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | €22,443 | €59,390 | €94,269 | ▲ 58.7% |
| + Depreciation and write-downs630 | €203 | €16,167 | €16,367 | ▲ 1.2% |
| Operating cash flow (approximation) | €22,646 | €75,557 | €110,636 | ▲ 46.4% |
| Investment in fixed assets (approximation) | - | -€5,130 | €0 | - |
| Change in cash | - | €92,364 | €36,800 | ▼ 60.2% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (3)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 27-04-2026 | 2026-00100007 |
| 31-12-2024 | micro format | 18-06-2025 | 2025-00151576 |
| 31-12-2023 | micro format | 03-07-2024 | 2024-00201182 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| Jean-Michel MOT |
|
Owners and capital
Capital and shareholders
- Jean-Michel MOT 100 shares (100%) · €3,000 in cash
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 03-07-2023 Incorporation · €3,000 · 100 shares
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
On 29 June 2023, DOTOMO was incorporated as a private limited company by one natural person, with a starting capital of €3,000.12 In 2024 the registered office moved to Amay.3 Jean-Michel MOT has served as director of the company since 2023.2 Total assets went from €90,500 in 2023 to €223,802 in 2025.4
Acts, filings and financial milestones
27-11
Gazette deed
Registered officeRegistered-office move2 facts ▸
- General meeting, 08-11-2024
- Registered-office move, Chaussée Roosevelt 21 bte 12 à 4540 Amay
03-07
Gazette deed
IncorporationAppointment: Jean-Michel MOT (director) · Registered office clause · Pre-incorporation commitments11 facts ▸
- Registered office clause, “4520 Wanze, rue Auguste Dony”, 17 (deed in French)
- Director appointment, Jean-Michel MOT (director)
- Pre-incorporation commitments, “takeover, tous engagements obligations résultantes et activités entrepris au nom et pour compte société en formation” (deed in French)
- Incorporation, “DOTOMO” (deed in French)
- Founder, Jean-Michel MOT
- Founding capital, €3,000
- Other provision, “avantages particuliers liés à la constitution, fondateur ou personne ayant participé directement ou indirectement à la constitution” (deed in French)
- Other provision, “conformité du dépôt de libération”, EUR (deed in French)
- Other provision, “arrêt des statuts, arrête les statuts” (deed in French)
- Capital
- Other provision, “compte de capitaux propres statutairement indisponible” (deed in French)
Register details
No listing in the Peppol Directory under this enterprise or VAT number. That proves nothing: being listed there is voluntary.
What can you do?
Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.
If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if you send it electronically, you need their agreement on a secure channel. The invoice remains valid; it is the customer, not you, who risks a penalty. FPS Finance
If you follow this company, Checked tells you the day it appears in the Peppol register.
Register as of 29 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 61003B0263/00V000 | Wallonia | 1,439 m² | 1 · 120 m² | - |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “L'exercice de la médecine et de l’art de guérir, par le ou les actionnaires qui la composent, lesquels sont exclusivement des médecins…” (deed in French)
5 activities (deed in French)
- L'exercice de la médecine et de l’art de guérir, par le ou les actionnaires qui la composent, lesquels sont exclusivement des médecins inscrits au Tableau de l'Ordre des Médecins ou des sociétés de médecins à personnalité juridique dont les statuts ont été approuvés par le Conseil de l’Ordre des Médecins
- L’exercice de la médecine d’urgence
- En cas de pluralité d’actionnaires, ceux-ci mettent en commun la totalité de leur activité médicale au sein de la société
- À titre accessoire et suivant des modalités arrêtées par les associés en ce qui concerne les investissements, la gestion et la valorisation d'un patrimoine immobilier, notamment par l'achat, de la pleine propriété ou de droits réels, la vente, la location, la mise en location, la construction, le tout au sens le plus large, pour autant que n'en soit altéré ni son caractère ni sa vocation première exclusivement médicale
- Louer ou sous-louer, acquérir des droits réels ou la pleine propriété de tout immeuble dans le but d'y établir son siège et/ou un siège d'exploitation, soit d'y loger ses dirigeants et les membres de leur famille
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- DOTOMO
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région wallonne, par simple décision organe d’administration peut établir sièges administratifs,agences,ateliers,dépôts et succursales en…” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “6 ans, 1” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “Nominatives, registre actions nominatives avec mentions CSA” (deed in French)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- One provision in the deed
- Share issue ruleHow and by whom new shares can be issued.
- “Organe qui procède à émission, souscription par personnes à cession libre selon loi ou article 9 ou tiers moyennant agrément moitié au moins…” (deed in French)
Oversight and winding up
- Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one.
- No statutory auditor
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Formes prévues pour modifications aux statuts, assemblée générale” (deed in French)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Si aucun autre liquidateur désigné, quelque cause et à quelque moment que ce soit” (deed in French)